<DOC>
	<DOCNO>NCT01511770</DOCNO>
	<brief_summary>The objective study open-label , randomize , 2-way crossover compare single-dose relative bioavailability Dr. Reddy 's Laboratories , Ltd. Pfizer ( Diflucan® ) 200 mg fluconazole tablet fast condition .</brief_summary>
	<brief_title>Bioavailability Study Fluconazole Tablets 200 mg Under Fasting Conditions</brief_title>
	<detailed_description>Detailed Description : The study conduct open-label , randomize , single-dose , 2-way crossover , relative bioavailability study perform 18 healthy adult male volunteer . A total 17 subject complete clinical phase study . In period , subject house morning dose 72-hour blood draw . Single oral 200 mg dos separate washout period 21 day .</detailed_description>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>History presence significant : • cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic psychiatric disease . In addition , history presence : alcoholism drug abuse within past year ; hypersensitivity idiosyncratic reaction fluconazole azoles . Subjects use drug substance know strong inhibitor CYP ( cytochrome P450 ) enzymes within 10 day prior first dose . Subjects use drug substance know strong inducer CYP ( cytochrome P450 ) enzymes within 28 day prior first dose . Subjects abnormal diet ( whatever reason ) 28 day prior first dose . Subjects , completion study , would donate excess : 500 mL blood 14 day , 500 750 mL blood 14 day ( unless approve Principal Investigator ) , 1000 mL blood 90 day , 1250 mL blood 120 day , 1500 mL blood 180 day , 2000 mL blood 270 day , 2500 mL blood 1 year . Subjects participate another clinical trial within 28 day prior first dosing .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Crossover</keyword>
</DOC>